Ftse Mib
33.028,48
-0,42%
DAX
19.244,44
-0,31%
S&P 500
5.994,64
-0,45%
NASDAQ
19.024,53
-0,79%
Bitcoin
95.613,39
3,99%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sarepta Therapeutics Inc New (SRPT) Sarepta Therapeutics Inc New (SRPT) Notizie

Sarepta Therapeutics Inc New

SRPT
134,49
3,99 (3,06%)
Ultimo aggiornamento: 16:47:03
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/11/202413:17EDGAR2Form 8-K - Current report
26/11/202413:00BWSarepta Therapeutics Announces Global Licensing and..
21/11/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202415:40EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202416:27EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:05BWSarepta Therapeutics Announces Third Quarter 2024 Financial..
06/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202421:10BWSarepta Therapeutics Announces Inducement Grants Under..
23/10/202414:30BWSarepta Therapeutics to Announce Third Quarter 2024..
30/9/202422:39BWSarepta Therapeutics Announces Inducement Grants Under..
26/9/202414:30BWSarepta Therapeutics to Present New Data from its..
17/9/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202402:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/9/202414:51EDGAR2Form 8-K - Current report
16/9/202414:30BWSarepta Therapeutics Appoints Deirdre Connelly to its Board..
06/9/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202415:00BWSarepta Therapeutics Announces Recipients of the 7th Annual..
04/9/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202423:03EDGAR2Form 144 - Report of proposed sale of securities
30/8/202422:10BWSarepta Therapeutics Announces Inducement Grants Under..
30/8/202414:30BWSarepta Therapeutics to Present at the Morgan Stanley 22nd..
20/8/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202411:53IHMARKETNEWSBumble Plunges 36% on Weak Revenue; Warner Bros. Reports..
07/8/202422:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202422:05BWSarepta Therapeutics Announces Second Quarter 2024 Financial..
07/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202411:49IHMARKETNEWSUS Index Futures Rise Amid Earnings Season Optimism, Oil..
31/7/202422:15BWSarepta Therapeutics Announces Inducement Grants Under..
29/7/202413:00BWSarepta Therapeutics to Announce Second Quarter 2024..
17/7/202414:00GLOBECassava Sciences Announces Changes in Executive Leadership,..
09/7/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202400:30BWSarepta Therapeutics Announces Inducement Grants Under..
21/6/202414:00IHMARKETNEWSHoneywell Acquires CAES Systems for $1.9 Billion, Sarepta..
20/6/202423:02BWSarepta Therapeutics Announces Expanded US FDA Approval of..
14/6/202413:21IHMARKETNEWSAdobe Soars 15% Pre-Market; Visa and Mastercard Encounter..
07/6/202422:45EDGAR2Form 8-K - Current report
31/5/202423:45BWSarepta Therapeutics Announces Inducement Grants Under..
29/5/202423:48PRNUSSarepta Therapeutics Set to Join S&P MidCap 400
07/5/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202402:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/5/202416:07BWGene Therapy Pioneer Jerry R. Mendell, M.D., Named to..
01/5/202422:05BWSarepta Therapeutics Announces First Quarter 2024 Financial..
01/5/202400:38BWSarepta Therapeutics Announces Inducement Grants Under..
24/4/202414:30BWSarepta Therapeutics to Announce First Quarter 2024..
29/3/202421:00BWSarepta Therapeutics Announces Inducement Grants Under..
08/3/202423:38EDGAR2Form 144 - Report of proposed sale of securities
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 130,94 Min: 130,00 Max: 135,49
Chiusura: 130,50

La tua Cronologia

NASDAQ
SRPT
Sarepta Therapeutics
BOV
TGTB34
Target Corporation DRN
LSE
XFVT
Xftse Vietnamsw
BOV
N2LY34M
Annaly Capital Management
BIT
S29820
Societe Generale Effekten
BIT
UB5UK1
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network